The tweet was deleted by the author.
But we saved everything 🙂.
CDW shares the story of Kate, who transitioned from healthcare into IT at the company, according to CDW.
Kate brought people skills, leadership and relationship building to her new role. Details are being clarified.
CDW is trading at $137.35, which stands above the MA-20 ($114.92) and MA-50 ($123.28), reflecting ongoing short- and medium-term strength, but sits just below the MA-200 ($138.02), suggesting lingering long-term pressure from sellers. The Ichimoku Kijun is at $119.29, which is below the current price and thus acts as immediate support. Near-term supports are seen at MA-50 ($123.28) and the Ichimoku Kijun ($119.29), while resistance comes from MA-200 ($138.02) and HMA ($142.88) as key levels.
Momentum remains constructive with MACD and ADX on D1 in “Buy” territory, though several oscillators indicate elevated or overbought conditions: Stoch RSI shows “Neutral,” CCI signals “Overbought,” and BBP highlights persistent buyer dominance. RSI on D1 prints 60.47, slightly elevated, and the Awesome Oscillator supports the upward move. In today’s session, the stock jumped 3.24%, highlighting strong intraday buying interest. Over the past week, CDW is up $4.31 (3.27%) from a previous close of $133.04, with the current price sitting in the middle of the weekly range. Weekly volatility amplitude stands at 6.78%, and the tone suggests ongoing consolidation near mid-range rather than a directional breakout.
For the coming week, an adjusted forecast range of $132 to $142 is likely, keeping within a 5–7% band around the current price and well above the 52-week low ($97.12) but still far from the 52-week high ($183.91). The probability of a price increase is moderate at 25%, based on one “Buy” signal (RSI-W1, ADX-W1) out of four core weekly indicators, making a decline more likely. The baseline scenario sees CDW oscillating between $132 and $142. A bullish breakout above $142 would target resistance levels near MA-200, while a bearish move below $132 exposes medium-term support. This week’s price action is expected to remain contained, with technical signals pointing to sideways-to-slightly-bearish bias unless fresh momentum emerges.
In a recent review, CDW was described as exhibiting resilience amid mixed momentum signals, with the stock expected to move sideways absent a clear breakout or breakdown. This article reassesses those dynamics in light of current market developments, with the key upside risk now hinging on whether CDW can sustain momentum above its recent consolidation.